BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2277791)

  • 1. [Effect of thymus extract TFX (Polfa) on hemoglobin level and peripheral blood erythrocyte count].
    Lewandowicz J
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):471-2. PubMed ID: 2277791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of treatment outcome in patients with rheumatoid arthritis treated with TFX- Polfa or gold salts after a one year follow up].
    Lewandowicz J
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1102-4. PubMed ID: 1305735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trial of the treatment of rheumatoid arthritis with TFX (thymus factor X)].
    Lasisz B; Zdrojewicz Z; Dul W; Strychalski J
    Wiad Lek; 1990 Sep 1-15; 43(17-18):870-3. PubMed ID: 2278144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial observations on the administration of thymus extract (TFX) in patients with alimentary tract neoplasms.
    Cybulski L; Turowski G; Politowski M; Urban A; Turaszwili T; Zubel M
    Pol Med Sci Hist Bull (1973); 1976; 15(1):47-9. PubMed ID: 995755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A trial of treatment with thymus factor (TFX) for chronic autoimmune hemolytic anemias].
    Słomkowski M
    Pol Merkur Lekarski; 1996 Nov; 1(5):327-8. PubMed ID: 9273208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary evaluation of the results of treatment of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa)].
    Juszczyk J
    Pol Tyg Lek; 1984 Aug; 39(33):1085-9. PubMed ID: 6504737
    [No Abstract]   [Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calf thymus extract (TFX-Polfa) in the treatment of pollinosis. Clinical trials by the double-blind method using a placebo].
    Kowalski ML; Kuna P; Grzegorczyk J; Rozniecki J
    Pol Tyg Lek; 1987 Jun; 42(24):739-42. PubMed ID: 3313315
    [No Abstract]   [Full Text] [Related]  

  • 10. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of calf thymus extract (TFX-POLFA) on growth of the subcutaneous transplant of Ehrlich's carcinoma.
    Chłap Z; Jaszcz W; Turowski G
    Mater Med Pol; 1984; 16(1):37-42. PubMed ID: 6527572
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effectiveness of the immuno stimulating extract of the calf thymus (TFX-Polfa) in cases of acute dermatomyositis].
    Stasiak A; Dudkiéwicz H; Dabrowski M; Dabrowska B; Wasowska B; Brzosko W
    Pol Tyg Lek; 1983 Mar; 38(13):389-92. PubMed ID: 6605525
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Evaluation of the efficiency of cellular mechanisms of the immunologic response].
    Dabrowska-Bernstein BK; Dabrowski MP; Stasiak A; Wasowska B; Brzosko WJ
    Pol Tyg Lek; 1984 Aug; 39(33):1091-6. PubMed ID: 6334280
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Clinical evaluation].
    Cianciara J; Babiuch L; Górska E; Kassur B
    Pol Tyg Lek; 1984 Aug; 39(33):1097-101. PubMed ID: 6390376
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possibility of using TFX (thymus factor X) in the treatment of systemic lupus erythematosus].
    Lasisz B; Zdrojewicz Z; Dul W; Markiewicz A; Strychalski J
    Pol Tyg Lek; 1989 Jul 23-30; 44(30-31):724-5. PubMed ID: 2701749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the results of the treatment of patients with subacute sclerosing panencephalitis with TFX-Polfa].
    Vainiene M; Sobczyk W
    Neurol Neurochir Pol; 1985; 19(4):286-90. PubMed ID: 2419779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of therapy on iron metabolism in patients with progressive chronic polyarthritis].
    Siering H; Eitner K
    Z Gesamte Inn Med; 1970 Sep; 25(18):827-30. PubMed ID: 5522138
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic application of calf thymus extract (TFX).
    Skotnicki AB
    Med Oncol Tumor Pharmacother; 1989; 6(1):31-43. PubMed ID: 2657248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of thymus factor (TFX "Polfa") on migration of granulocytes in vivo and in vitro in patients treated for a long time with corticosteroids.
    Matusiewicz R; Waśniewski J
    Arch Immunol Ther Exp (Warsz); 1988; 36(3):361-5. PubMed ID: 3250357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
    Forster PJ; McConkey B
    Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.